Journal Information
Vol. 47. Issue 5.
Pages 224-225 (January 2011)
Vol. 47. Issue 5.
Pages 224-225 (January 2011)
Editorial
Full text access
Quality of Forced Spirometry in Primary Care, Impact on the COPD Treatment
La espirometría forzada de calidad en Atención Primaria, impacto en el tratamiento de la EPOC
Visits
4078
Felip Burgos
Servicio de Neumología, ICT, Hospital Clínic, Barcelona, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
D.M. Mannino, S.A. Buist, T.L. Petty, P.L. Enright, C.S. Redd.
Lung function and mortality in the United Status: data from the First Matinal Health and Nutritional Examination Survey follow-up study.
Thorax, 58 (2003), pp. 388-393
[2.]
P.G.J. Burney, R. Hooper.
Forced vital capacity, airway obstruction and survival in a general population sample from the USA.
Thorax, 66 (2011), pp. 49-54
[3.]
H.M. Lee, H. Le, B.T. Lee, V.A. López, N.D. Wong.
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.
Eur Respir J, 36 (2010), pp. 1002-1006
[4.]
J.B. Soriano, J. Ancochea, M. Miravitlles, F. García-Río, E. Durán-Tauleria, L. Muñoz, et al.
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007.
Eur Respir J, 36 (2010), pp. 758-765
[5.]
K. Naberan, C. de la Roza, M. Lamban, E. Gobartt, A. Martín, M. Miravitlles.
Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care.
Arch Bronconeumol, 42 (2006), pp. 638-644
[6.]
D. Castillo, R. Guayta, J. Giner, F. Burgos, C. Capdevila, J.B. Soriano, FARMAEPOC group, et al.
COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
Respir Med, 103 (2009), pp. 839-845
[7.]
R.E. Dales, K.L. Vandemheen, J. Clinch, S.D. Aaron.
Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction.
Chest, 128 (2005), pp. 2443-2447
[8.]
M. Monteagudo, et al.
Variabilidad en la realización de la espirometría y sus consecuencias en el tratamiento de la EPOC en Atención Primaria.
Archiv. Bronconeumol, 47 (2011), pp. 226-233
[9.]
C. Pellicer, J.J. Soler-Cataluña, A. Andreu, J. Bueso.
Calidad del diagnóstico de la enfermedad pulmonar obstructiva crónica en el ámbito hospitalario.
Arch. Bronconeumol, 46 (2010), pp. 64-69
[10.]
J.J. Soler-Cataluña, M. Calle, B.G. Cosío, J.M. Marín, E. Monsó, I. Alfageme.
Comité de Calidad Asistencial de la SEPAR;Area de Trabajo EPOC de la SEPAR. Estándares de calidad asistencial en la EPOC.
Arch Bronconeumol, 45 (2009), pp. 196-203
[11.]
Peces-Barba G, Barberà JA, Agustí AGN, Casanova C, et al. Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC. Available from: http://www.separ.es/publicaciones/normativas.html. Arch Bronconeumol. 2008;44:271–8.
[12.]
R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, S.S. Hurd, GOLD Scientific Committee.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[13.]
Telemetric developments in respiratory monitoring. J. Roca, B. Vallespín, F. Burgos. The Buyers’ Guide to Respiratory Care Products, 2008.
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica